Laparoscopic- Vs Ultrasound-guided Transversus Abdominis Plane Block in Laparoscopic Colectomy: a Prospective Randomized Controlled Trial
Overview
- Phase
- Not Applicable
- Intervention
- laparoscopic-assisted Transversus Abdominis Plane (TAP) block
- Conditions
- Laparoscopic Colectomy
- Sponsor
- Davide La Regina
- Enrollment
- 116
- Locations
- 2
- Primary Endpoint
- Opioids consumption
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
The purpose of this study is to compare the postoperative pain, the time needed and other clinical outcomes in patients who, during laparoscopic colectomy, will be injected with a local anesthetic (Ropivacaine) through an ultrasound guided technique performed by the anaesthesiologist or throught a laparoscopic assisted technique performed by the surgeon
Investigators
Davide La Regina
Principal Investigator
Ente Ospedaliero Cantonale, Bellinzona
Eligibility Criteria
Inclusion Criteria
- •Patients candidates to laparoscopic colorectal surgery
- •Signed informed consent
Exclusion Criteria
- •Age \< 18 years old
- •Pregnancy
- •Allergy to local anaesthetics
- •Spinal or epidural analgesia
- •Acute inflammatory abdominal pathologies
- •Chronic pain syndrome
- •Contraindications to nonsteroidal anti-inflammatory drugs (NSAIDS)
Arms & Interventions
Laparoscopic Transversus Abdominis Plane (L-TAP) group
Patients will undergo the planned laparoscopic colectomy according to the standard of treatment. A solution of 15 ml of Ropivacaine (0.2%) is then injected for postoperative pain under laparoscopic control
Intervention: laparoscopic-assisted Transversus Abdominis Plane (TAP) block
Laparoscopic Transversus Abdominis Plane (L-TAP) group
Patients will undergo the planned laparoscopic colectomy according to the standard of treatment. A solution of 15 ml of Ropivacaine (0.2%) is then injected for postoperative pain under laparoscopic control
Intervention: Ropivacaine
Ultrasound Transversus Abdominis Plane (U-TAP) group
Patients will undergo the planned laparoscopic colectomy according to the standard of treatment. A solution of 15 ml of Ropivacaine (0.2%) is then injected for postoperative pain under ultrasound control
Intervention: ultrasound-assisted Transversus Abdominis Plane (TAP) block
Ultrasound Transversus Abdominis Plane (U-TAP) group
Patients will undergo the planned laparoscopic colectomy according to the standard of treatment. A solution of 15 ml of Ropivacaine (0.2%) is then injected for postoperative pain under ultrasound control
Intervention: Ropivacaine
Outcomes
Primary Outcomes
Opioids consumption
Time Frame: 24 hours from surgery
Opioid consumption measured in morphine milligram equivalents (MME) per day
Secondary Outcomes
- Time required to perform the (Transversus Abdominis Plane) TAP block(during procedure)
- Opioid consumption within the first 48 hours after the operation(48 hours from surgery)
- postoperative pain(at 3, 6, 12, 24 hours from surgery)
- length of hospital stay(during hospitalization,approximately 6 days)